Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia-Reference-Cited by-同舟云学术

Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia

Published:2005-11-10 Issue:12 Volume:19 Page:2232-2240
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Christiansen D H,Andersen M K,Desta F,Pedersen-Bjergaard J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404009.pdf

Reference49 articles.

1. Deguchi K, Gilliland DG . Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia 2002; 16: 740–744.

2. Kelly LM, Gilliland DG . Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002; 3: 179–198.

3. Blume-Jensen P, Hunter T . Oncogenic kinase signalling. Nature 2001; 411: 355–365.

4. Gilliland DG, Griffin JD . The role of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532–1542.

5. Stirewalt DL, Radich JP . The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 2003; 3: 650–665.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience;International Journal of Molecular Sciences;2024-05-09

2. BRAF mutation in myeloid neoplasm: incidences and clinical outcomes;Leukemia & Lymphoma;2024-05-02

3. CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature;Frontiers in Oncology;2024-01-25

4. Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy;Biology Direct;2024-01-04

5. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice;Journal of Clinical Investigation;2023-12-15